Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Inhaled aerosol viral-vectored vaccines against tuberculosis.

Stylianou E. and Satti I., (2024), Current opinion in virology, 66

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)

Tanner R. et al, (2021)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model.

Pinpathomrat N. et al, (2021), Vaccine

Identification of antigens presented by MHC for vaccines against tuberculosis

Bettencourt P. et al, (2020), npj Vaccines, 5

Identification of antigens presented by MHC for vaccines against tuberculosis.

Bettencourt P. et al, (2020), NPJ vaccines, 5

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges.

Stylianou E. et al, (2019), Expert review of vaccines, 18, 1271 - 1284

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin

McNeill E. et al, (2018), Nature Communications, 9

Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine

Stylianou E. et al, (2018), Infection and Immunity, 86, e00014 - 18

Enhancing the Biological Relevance of Machine Learning Classifiers for Reverse Vaccinology

Heinson A. et al, (2017), International Journal of Molecular Sciences, 18, 312 - 312

Correction: Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants

Fletcher HA. et al, (2016), Nature Communications, 7

T-cell activation is an immune correlate of risk in BCG vaccinated infants

Fletcher HA. et al, (2016), Nature Communications, 7

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A

Stylianou E. et al, (2015), Vaccine, 33, 6800 - 6808

Rgs-1 regulates leukocyte trafficking in atherosclerosis and aortic aneurysm formation through altered chemokine signalling

Patel J. et al, (2015), Atherosclerosis, 241, e11 - e11

RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling

Patel J. et al, (2015), Nature Communications, 6

Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo

Iqbal AJ. et al, (2014), Blood, 124, e33 - e44

Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG

Pepponi I. et al, (2014), Plant Biotechnology Journal, 12, 840 - 850

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis

Poyntz HC. et al, (2014), Tuberculosis, 94, 226 - 237

Mucosal delivery of antigen‐coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice

Stylianou E. et al, (2014), European Journal of Immunology, 44, 440 - 449

Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG

Pepponi I. et al, (2014), Plant Biotechnology Journal, 12, 840 - 850

Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice

Griffiths KL. et al, (2013), PLoS ONE, 8, e78312 - e78312

Load More

Include forthcoming?